Respiratory Viral Infection
📧 Sign up to get email alerts when something new happens for Respiratory Viral Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of Raphamin for acute respiratory viral infection in children aged 3-12, and …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections. [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of Ingavirin Forte Capsules at different doses for influenza and ot…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children [Phase 3]
Phase 3 study evaluating the efficacy and safety of Rengalin for acute respiratory viral infection-related cough in children; the trial is c…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Multi-center study evaluating molecular diagnosis and host response to respiratory viral infections in pediatric hematopoietic cell transpla…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males [Phase 1]
Phase 1 pharmacokinetics and relative bioavailability of metabolites in healthy Chinese adult males; the trial status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.